European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (eortc) [and] European Association for Cancer Research (eacr)
Overview
The European Journal of Cancer is the official journal for the European Organization for Research and Treatment of Cancer (EORTC) and the European Association for Cancer Research (EACR). It publishes high-quality research articles, reviews, and commentaries on all aspects of cancer research and treatment, with a focus on advancing knowledge and improving patient outcomes in Europe and beyond.
Details
Details
Abbr.
Eur J Cancer
Start
1990
End
Continuing
Frequency
Eighteen no. a year, 2000-
p-ISSN
0959-8049
e-ISSN
1879-0852
Country
United Kingdom
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 392
245
SJR / Ranks: 825
2501
CiteScore / Ranks: 1136
11.10
JIF / Ranks: 623
8.4
Recent Articles
21.
Han R, Guo H, Shi J, Wang H, Zhao S, Jia Y, et al.
Eur J Cancer
. 2025 Feb;
219:115307.
PMID: 39984319
No abstract available.
22.
Maglietta G, Damato A, Finotto S, Mandara M, Tamberi S, Grisanti S, et al.
Eur J Cancer
. 2025 Feb;
219:115296.
PMID: 39970525
Background: The oral factor Xa inhibitor, edoxaban, is effective and safe in cancer-associated Venous Thromboembolism (VTE) treatment. The EDOI study aims to evaluate compliance and quality of life (QoL) in...
23.
Wislez M, Mascaux C, Cadranel J, Thomas Q, Ricordel C, Swalduz A, et al.
Eur J Cancer
. 2025 Feb;
219:115301.
PMID: 39970524
Introduction: Sotorasib has shown efficacy in a phase 3 trial compared to docetaxel among previously treated non-small cell lung cancer (NSCLC) patients with a KRAS G12C mutation. However, its real-world...
24.
Peirelinck H, De Gendt C, Lenssen O, Nuyts S, Van Eycken L
Eur J Cancer
. 2025 Feb;
218:115300.
PMID: 39965995
No abstract available.
25.
Walstra A, Lancaster H, Heuvelmans M, van der Aalst C, Hubert J, Moldovanu D, et al.
Eur J Cancer
. 2025 Feb;
218:115294.
PMID: 39965286
No abstract available.
26.
Hollis R, Churchman M, Grimes G, Meynert A, Gautier P, McMahon L, et al.
Eur J Cancer
. 2025 Feb;
219:115299.
PMID: 39955805
Background: Half of high grade serous tubo-ovarian carcinomas (HGSOC) demonstrate homologous recombination repair (HRR) deficiency, most commonly through germline or somatic pathogenic variants in BRCA1/2 (gBRCA1/2 or sBRCA1/2). gBRCA1/2 is...
27.
Langenberg K, van Hooff S, Koopmans B, Strijker J, Kholosy W, Ober K, et al.
Eur J Cancer
. 2025 Feb;
218:115275.
PMID: 39954414
Introduction: Despite druggable events to be present in 80 % of neuroblastomapatients within the Princess Máxima Center precision medicine program 'iTHER', clinical uptake of treatment recommendations has been low, and...
28.
Leibetseder A, Mair M, Serra A, Spiro Z, Aichholzer M, Widhalm G, et al.
Eur J Cancer
. 2025 Feb;
218:115259.
PMID: 39954413
Background: A significant proportion of women in reproductive age are diagnosed with diffuse gliomas, resulting in the need to address the safety of pregnancy in patient consultation. However, data on...
29.
Xu H, Hu Y, Xie T, Lu L, Yan Z, Chen X, et al.
Eur J Cancer
. 2025 Feb;
219:115305.
PMID: 39954311
Objective: To evaluate the applicability of the M1 category of the version-nine of AJCC/UICC TNM staging system (TNM-9) for M1 nasopharyngeal carcinoma (M1-NPC) in immunotherapy era and propose potential refinements....
30.
Sobrero A, Dasari A, Aquino J, Lonardi S, Garcia-Carbonero R, Elez E, et al.
Eur J Cancer
. 2025 Feb;
218:115268.
PMID: 39952149
Introduction: Maintaining or improving health-related quality of life (HRQoL) is as important as extending survival in metastatic colorectal cancer. We report an HRQoL analysis from FRESCO-2 (NCT04322539). Methods: Patients were...